Clinical Trials Using Rucaparib Camsylate
Clinical trials are research studies that involve people. The clinical trials on this list are studying Rucaparib Camsylate. All trials on the list are supported by NCI.
NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.
Rucaparib Camsylate and Irinotecan Hydrochloride in Treating Patients with Advanced Solid Tumors with Mutations in DNA Repair
This phase I trial studies the side effects and best dose of rucaparib camsylate and irinotecan hydrochloride in treating patients with solid tumors with mutations in deoxyribonucleic acid (DNA) repair that have spread to other places in the body. Rucaparib camsylate and irinotecan hydrochloride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Location: UCSF Medical Center-Mount Zion, San Francisco, California